^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    TQB2934

    i
    Other names: TQB2934
    Associations

    News

    Trials
    Company:
    Sino Biopharm
    Drug class:
    CD3 agonist, BCMA inhibitor
    Related drugs:
    Associations

    News

    Trials
    over1year
    A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects (clinicaltrials.gov)
    P1, N=140, Recruiting, Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Not yet recruiting --> Recruiting
    Enrollment open • IO biomarker
    |
    IL6 (Interleukin 6) • IL2 (Interleukin 2) • IL10 (Interleukin 10)
    |
    IL10 elevation
    |
    TQB2934
    2years
    A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects (clinicaltrials.gov)
    P1, N=140, Not yet recruiting, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
    New P1 trial • IO biomarker
    |
    IL6 (Interleukin 6) • IL2 (Interleukin 2) • IL10 (Interleukin 10)
    |
    TQB2934